We next used the CXCR4+ luciferase+ SW1417 SC CRC model to assess if the selective CXCR4+ cancer cell killing induced by T22‐GFP‐H6‐FdU treatment in vivo was capable of blocking spheroid formation in vitro. This evidence concerns the gene CXCR4 and cancer.